Quantcast

Latest Pulmonology Stories

2014-10-29 23:16:21

StratAcuity, The Science of People: StratAcuity successfully completes the search for the Proteostasis Therapeutics Inaugural Cystic Fibrosis Clinical Advisory Board. Boston, MA (PRWEB) October 29, 2014 StratAcuity successfully completes the search for the Proteostasis Therapeutics Inaugural Cystic Fibrosis Clinical Advisory Board. The newly appointed board will serve as a strategic resource for the upcoming selection and study of the Company's leading compounds that double the...

2014-10-28 12:31:07

Data Presented During Late Breaking Oral Session at CHEST 2014 AUSTIN, Texas, Oct. 28, 2014 /PRNewswire/ -- Results from a retrospective analysis of patients with chronic lung disease conducted by SCIO Health Analytics and validated by leading pulmonologists demonstrated that use of a portable non-invasive open ventilation system resulted in clinically significant improvements in the modified British Medical Research Council (mMRC) dyspnea scale and the COPD Assessment Test (CAT)....

2014-10-27 12:29:25

Data for the co-administration of Spiriva® HandiHaler® (tiotropium bromide inhalation powder) + Striverdi® Respimat® (olodaterol) Inhalation Spray presented at CHEST 2014 RIDGEFIELD, Conn., Oct. 27, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented data from the ANHELTO(TM) 1&2 studies (NCT01694771/NCT01696058) that evaluated the co-administration of Spiriva® HandiHaler® (tiotropium bromide inhalation powder) (T) plus Striverdi® Respimat® (olodaterol) Inhalation...

2014-10-23 08:33:55

ANDOVER, Mass., Oct. 23, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative, mobile pulmonary function testing (PFT) technology is donating EasyOne Plus® devices for an October 27 free screening during Austin Lung Health Day. Nearly one in ten Austin, Texas residents have been diagnosed with chronic obstructive pulmonary disease (COPD) and the same number may be undiagnosed, based on national averages. COPD is the 3(rd) leading cause of death in the U.S. The...

2014-10-17 08:25:14

ANDOVER, Mass., Oct. 17, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro® is now being used by the Choctaw Nation Healthcare Center, a 140,000 square foot, 44-bed hospital with many outpatient services. The Talihina, Oklahoma hospital serves a large number of Native Americans from several tribes living in southeastern Oklahoma and beyond. A portion of...

2014-10-16 12:30:21

First FDA Approved Treatments in United States for Devastating Lung Disease Affecting More than 200,000 Americans, with Survival Rate of Just Three to Five Years CHICAGO, Oct. 16, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) applauds the approval of Esbriet(®) (pirfenidone) and OFEV(®) (nintedanib) by the U.S. Food and Drug Administration (FDA) as the first disease-specific therapies for idiopathic pulmonary fibrosis (IPF) in the United States....

2014-10-15 12:31:48

The COPD Market Will Fracture with the Continuing Entry of LABA/LAMAs and Other Later-to-Market Bronchodilators, According to Findings from Decision Resources Group BURLINGTON, Mass., Oct. 15, 2014 /PRNewswire/ -- Decision Resources Group finds that the emergence of the long-acting beta(2) agonist (LABA)/long-acting muscarinic antagonist (LAMA) drug class will help drive total sales across the chronic obstructive pulmonary disease (COPD) market in the United States, France, Germany, Italy,...

2014-10-15 08:30:43

NIH Awards Two Grants to Academic Partners to Progress Mucolytic Research Program DURHAM, N.C., Oct. 15, 2014 /PRNewswire-USNewswire/ -- Parion Sciences, a company dedicated to the development of novel treatments for pulmonary and ocular diseases, announced today that the National Institutes of Health (NIH) has awarded up to $15.6 million over 5 years in grants to The University of North Carolina, Chapel Hill (UNC-CH) and The University of Colorado, Denver (UCD) to conduct research...

2014-10-14 20:23:15

-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct. 14, 2014 /PRNewswire/ -- "About 123,000 patients with atopic dermatitis, rhinitis, and asthma and 32,000 patients with pulmonary emphysema, bronchiectasis, and pulmonary fibrosis have been cured." http://photos.prnewswire.com/prnvar/20141014/151916 There is a Korean medicine doctor who has cured hundred thousands of lives of patients with chronic allergic conditions, only with Korean medicine. He...

2014-10-13 23:02:07

On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new facility, the Sleep Apnea Institute, and the expansion of a new treatment center for the Lung Institute. Tampa, FL (PRWEB) October 13, 2014 On Monday, October 20, Regenerative Medicine Solutions (RMS) is set to open its doors to two new clinics in Nashville, Tennessee. RMS welcomes the launch of an entirely new...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related